Inventor · disambiguated record
Edward T. Olejniczak
Also filed as: OLEJNICZAK EDWARD T · OLEJNICZAK Edward
17 granted patents·5 pending applications·189 citations·filing 1995–2022
92Inventor score
Top patents by PatentIndex Score
22 records- 0188US8263558B2Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteinsHOLZMAN THOMAS F·Filed 2006·Granted Sep 11, 2012·23 cites·14 claims
- 0287US10160763B2WDR5 inhibitors and modulatorsUNIV VANDERBILT·Filed 2017·Granted Dec 25, 2018·5 cites·21 claims
- 0384US10501466B2WDR5 inhibitors and modulatorsUNIV VANDERBILT·Filed 2018·Granted Dec 10, 2019·3 cites·20 claims
- 0483US8846036B2Antibodies that bind to mammalian NGAL and uses thereofBIRKENMEYER LARRY G·Filed 2008·Granted Sep 30, 2014·5 cites·28 claims
- 0583US5891643AUse of nuclear magnetic resonance to design ligands to target biomoleculesABBOTT LAB·Filed 1995·Granted Apr 6, 1999·67 cites·8 claims
- 0680US10533010B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2015·Granted Jan 14, 2020·3 cites·15 claims
- 0775US12144816B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2022·Granted Nov 19, 2024·0 cites·16 claims
- 0875US6043024AUse of one-dimensional nuclear magnetic resonance to identify ligands to target biomoleculesABBOTT LAB·Filed 1997·Granted Mar 28, 2000·38 cites·17 claims
- 0975US5989827AUse of nuclear magnetic resonance to design ligands to target biomoleculesABBOTT LAB·Filed 1996·Granted Nov 23, 1999·44 cites·8 claims
- 1074US11596639B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2017·Granted Mar 7, 2023·1 cites·20 claims
- 1173US12195472B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2021·Granted Jan 14, 2025·0 cites·17 claims
- 1267US11208415B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2019·Granted Dec 28, 2021·0 cites·17 claims
- 1365US10005728B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2014·Granted Jun 26, 2018·0 cites·25 claims
- 1461US10954193B2Substituted indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2018·Granted Mar 23, 2021·0 cites·19 claims
- 1556US10844032B2Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitorsUNIV VANDERBILT·Filed 2018·Granted Nov 24, 2020·0 cites·20 claims
- 1656US10093640B2Substituted benzofuran, benzothiophene and indole MCL-1 inhibitorsUNIV VANDERBILT·Filed 2013·Granted Oct 9, 2018·0 cites·21 claims
- 1751US2009123946A1Immunoassays and kits for the detection of ngalABBOTT LAB·Filed 2008·Application pending·0 cites
- 1850US2009124022A1Antibodies that bind to mammalian ngal and uses thereofABBOTT LAB·Filed 2008·Application pending·0 cites
- 1949US2011092445A1Amyloid ß peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their usesABBOTT LAB·Filed 2009·Application pending·0 cites
- 2049US2009269777A1Immunoassays and kits for the detection of ngalABBOTT LAB·Filed 2008·Application pending·0 cites
- 2140US2010227775A1Immunoassays and kits for the detection of ngalABBOTT LAB·Filed 2010·Application pending·0 cites
- 2236US9949965B2Tricyclic indole Mcl-1 inhibitors and uses thereofUNIV VANDERBILT·Filed 2015·Granted Apr 24, 2018·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Edward T. Olejniczak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →